ES2337773T3 - Antigenos de streptococcus del grupo b y fragmentos de adn correspondientes. - Google Patents

Antigenos de streptococcus del grupo b y fragmentos de adn correspondientes. Download PDF

Info

Publication number
ES2337773T3
ES2337773T3 ES02745009T ES02745009T ES2337773T3 ES 2337773 T3 ES2337773 T3 ES 2337773T3 ES 02745009 T ES02745009 T ES 02745009T ES 02745009 T ES02745009 T ES 02745009T ES 2337773 T3 ES2337773 T3 ES 2337773T3
Authority
ES
Spain
Prior art keywords
amino acid
polypeptide
seq
acid sequence
baselineskip
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02745009T
Other languages
English (en)
Spanish (es)
Inventor
Denis Martin
Stephane Rioux
Bernard R. Brodeur
Josee Hamel
Martine Boyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ID BIOMEDICAL CORP
ID Biomedical Corp of Quebec
Original Assignee
ID BIOMEDICAL CORP
ID Biomedical Corp of Quebec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ID BIOMEDICAL CORP, ID Biomedical Corp of Quebec filed Critical ID BIOMEDICAL CORP
Application granted granted Critical
Publication of ES2337773T3 publication Critical patent/ES2337773T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES02745009T 2001-07-06 2002-07-05 Antigenos de streptococcus del grupo b y fragmentos de adn correspondientes. Expired - Lifetime ES2337773T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30310101P 2001-07-06 2001-07-06
US303101P 2001-07-06

Publications (1)

Publication Number Publication Date
ES2337773T3 true ES2337773T3 (es) 2010-04-29

Family

ID=23170538

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02745009T Expired - Lifetime ES2337773T3 (es) 2001-07-06 2002-07-05 Antigenos de streptococcus del grupo b y fragmentos de adn correspondientes.

Country Status (10)

Country Link
US (2) US7393536B2 (enExample)
EP (1) EP1407023B1 (enExample)
JP (2) JP4374245B2 (enExample)
AT (1) ATE452191T1 (enExample)
AU (1) AU2002317107B2 (enExample)
BR (1) BR0210875A (enExample)
CA (1) CA2453062C (enExample)
DE (1) DE60234772D1 (enExample)
ES (1) ES2337773T3 (enExample)
WO (1) WO2003004650A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939087B2 (en) * 2000-10-27 2011-05-10 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from Streptococcus groups A & B
EP1343895B1 (en) * 2000-12-21 2008-06-18 ID Biomedical Corporation Streptococcus pyogenes antigens and corresponding dna fragments
JP2005514052A (ja) * 2001-12-21 2005-05-19 チルドレンズ ホスピタル アンド レジオナル メディカル センター Ｂ群連鎖球菌の新規の細胞表面プロテアーゼの使用
WO2012138470A2 (en) 2011-04-04 2012-10-11 Intelligent Medical Devices, Inc. Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantitation, monitoring, screening, and sequencing of group b streptococcus
KR101675382B1 (ko) 2015-04-07 2016-11-14 (주) 씨에스코리아 황토보드 제조방법 및 그에 의해 제조되는 황토보드

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0618813B1 (en) 1992-09-16 2002-01-09 The University Of Tennessee Research Corporation Antigen of hybrid m protein and carrier for group a streptococcal vaccine
DE69836744T2 (de) 1997-09-12 2007-10-04 University Of Tennessee Research Foundation, Knoxville Gruppe a streptokokken-impfstoff
PL205041B1 (pl) 1998-12-23 2010-03-31 Id Biomedical Corp Izolowany polinukleotyd, wektor zawierający izolowany polinukleotyd, komórka gospodarza transfekowana lub transformowana za pomocą tego wektora, sposób wytwarzania polipeptydu kodowanego przez izolowany polinukleotyd, izolowany polipeptyd, chimeryczny polipeptyd, kompozycja do szczepionek zawierająca polipeptyd oraz jej zastosowanie w leczeniu lub zapobieganiu zakażeniu osobnika paciorkowcem
GB9921125D0 (en) 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
US7939087B2 (en) * 2000-10-27 2011-05-10 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from Streptococcus groups A & B
FR2824074A1 (fr) 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
US7262024B2 (en) 2001-12-20 2007-08-28 Id Biomedical Corporation Streptococcus antigens

Also Published As

Publication number Publication date
CA2453062A1 (en) 2003-01-16
US7740870B2 (en) 2010-06-22
JP5194199B2 (ja) 2013-05-08
BR0210875A (pt) 2004-06-22
CA2453062C (en) 2013-04-02
US20040242844A1 (en) 2004-12-02
WO2003004650A2 (en) 2003-01-16
JP2009240316A (ja) 2009-10-22
JP2005501534A (ja) 2005-01-20
DE60234772D1 (de) 2010-01-28
JP4374245B2 (ja) 2009-12-02
AU2002317107B2 (en) 2008-06-12
EP1407023B1 (en) 2009-12-16
US7393536B2 (en) 2008-07-01
ATE452191T1 (de) 2010-01-15
EP1407023A2 (en) 2004-04-14
US20090042794A1 (en) 2009-02-12
WO2003004650A3 (en) 2003-05-30

Similar Documents

Publication Publication Date Title
ES2400280T3 (es) Antígenos de estreptococos
ES2540281T3 (es) Antígenos de estreptococos del grupo B
ES2316458T3 (es) Antigeno de streptococcus pyogenes.
US9340586B2 (en) Streptococcus pyogenes antigens and corresponding DNA fragments
ES2381967T3 (es) Antígeno de streptococcus del grupo B
US7740870B2 (en) Group B Streptococcus antigens and corresponding DNA fragments
ES2435923T3 (es) Antígenos de Haemophilus influenzae y los correspondientes fragmentos de ADN
ES2338637T3 (es) Polipeptidos de streptococcus pyogenes y fragmentos de adn correspondiente.
ES2382893T3 (es) Antígenos BVH-A2 y BVH-3 de streptococcus del grupo B
AU2002317107A1 (en) Group B streptococcus antigens and corresponding DNA fragments
ES2316563T3 (es) Antigenos de moraxella (branhamella) catarrhalis.
ES2432013T3 (es) Composiciones farmacéuticas para usar en el tratamiento de la infección por Streptococcus Pyogenes
ES2316627T3 (es) Polipeptidos de moraxella (branhamella) catarrhalis.
EP1399563B1 (en) Moraxella (branhamella) catarrhalis antigens
US20040171113A1 (en) Antigens of group b streptococcus and corresponding dna fragments
WO2004048575A2 (en) Streptococcus pneumoniae surface polypeptides